Odycin (Clarithromycin)

Clarithromycin is a macrolide antibiotic used to treat bacterial infections of the respiratory tract, skin and gastrointestinal system.

• Community‑acquired pneumonia: eradicates the causative bacteria, improving respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms.
• Skin and soft‑tissue infections: clears bacterial pathogens, promoting wound healing.
• Helicobacter pylori eradication: contributes to bacterial clearance when combined with other agents in a multi‑drug regimen.

• Clarithromycin binds to the 50S subunit of bacterial ribosomes, blocking the translocation step of protein synthesis. This inhibition prevents peptide chain elongation, halting bacterial growth and leading to a bacteriostatic effect against susceptible organisms. Its activity is concentration‑dependent and covers many Gram‑positive, some Gram‑negative and atypical bacteria.

Clarithromycin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: frequent loose stools.
• Abdominal pain: cramping or discomfort.
• Taste disturbance: altered or metallic taste.
• Headache: mild to moderate.
• Vomiting: occasional episodes.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• QT interval prolongation: may predispose to cardiac arrhythmias.
• Clostridioides difficile infection: severe colitis.
• Hepatotoxicity: elevated liver enzymes or liver injury.
• Severe arrhythmias: especially in patients with pre‑existing cardiac conditions.
• Stevens‑Johnson syndrome: rare but life‑threatening skin reaction.

Before prescribing Clarithromycin, clinicians should consider several safety measures.

• Liver function assessment: monitor hepatic enzymes in patients with liver disease.
• Cardiac monitoring: avoid in patients with known QT prolongation or electrolyte disturbances.
• Allergy check: do not use in individuals with a documented macrolide hypersensitivity.
• Renal impairment: dose adjustment may be required for severe renal dysfunction.
• Drug interaction vigilance: review concomitant medications that affect QT interval or CYP3A4 metabolism.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Clarithromycin interacts with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid)

• Cisapride: risk of serious cardiac arrhythmias.
• Pimozide: may cause QT prolongation and torsades de pointes.
• Ergot alkaloids: increased risk of ergotism.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): can raise clarithromycin levels dramatically.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Statins (simvastatin, lovastatin): increased risk of myopathy.
• Digoxin: potential increase in serum concentrations.
• Oral contraceptives: possible reduction in efficacy, advise alternative contraception.